Bibliography
Export 24 results:
Filters: Keyword is *Hematopoietic Stem Cell Transplantation [Clear All Filters]
The monitoring of hematopoietic stem cell transplant donors and recipients from endemic areas for malaria. Revista do Instituto de Medicina Tropical de Sao Paulo//Rev Inst Med Trop Sao Paulo. 2010;52(5):281-4.
Is allergic disease curable or transferable with allogeneic hematopoietic cell transplantation?. Blood//Blood. 2009;113(2):279-90.
Regionally limited or rare infections: prevention after hematopoietic cell transplantation. Bone Marrow Transplant. 2009;44(8):489-94.
Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism. Xenotransplantation. 2006;13(2):126-32.
Hematopoietic progenitor cell transplantation from a donor with indeterminate human immunodeficiency virus antibody status. Transfusion. 2005;45(5):819-20.
Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts. Transfusion. 2005;45(6):874-8.
Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. Journal of Hepatology. 2005;42(6):813-9.
Circulatory arrest during PBPC apheresis in an unrelated donor. Transfusion. 2003;43(6):736-41.
Leukemia in donor cells after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant. 2002;29(12):999-1003.
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis. Journal of Clinical Apheresis. 2001;16(2):82-7.
Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method. Br J Haematol. 2001;113(4):1072-5.
Safety of granulocyte colony-stimulating factor in normal donors. Curr Opin Hematol. 2001;8(3):155-60.
Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet. 1999;353(9152):555.
Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation. Bone Marrow Transplantation. 1998;22(1):39-45.
Safe and efficient peripheral blood stem cell collection in the smallest of children. Therapeutic Apheresis. 1998;2(1):49-57.
Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant. 1997;3(1):45-9.
Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors. Transfusion. 1996;36(7):596-600.
Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures.[Erratum appears in Transfusion 1997 Jan;37(1):109]. Transfusion. 1996;36(7):590-5.
Guidelines for efficient peripheral blood progenitor cell collection. Netherlands Journal of Medicine. 1996;48(1):29-37.
Prolonged thrombocytopenia after administration of granulocyte colony-stimulating factor and leukapheresis in a donor for allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 1996;18(2):482-3.
Thrombocytopenia in allogeneic peripheral blood stem cell collections. Transfusion. 1996;36(7):668-9.
Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells. Bone Marrow Transplant. 1996;17 Suppl 2:S19-21.
Sustained cytopenia after leukapheresis for collection of peripheral blood stem cells in small children. Vox Sanguinis. 1989;57(3):168-71.